Unknown

Dataset Information

0

Pre-BCR signaling in precursor B-cell acute lymphoblastic leukemia regulates PI3K/AKT, FOXO1 and MYC, and can be targeted by SYK inhibition.


ABSTRACT: Precursor-B-cell receptor (pre-BCR) signaling and spleen tyrosine kinase (SYK) recently were introduced as therapeutic targets for patients with B-cell acute lymphoblastic leukemia (B-ALL), but the importance of this pathway in B-ALL subsets and mechanism of downstream signaling have not fully been elucidated. Here, we provide new detailed insight into the mechanism of pre-BCR signaling in B-ALL. We compared the effects of pharmacological and genetic disruption of pre-BCR signaling in vitro and in mouse models for B-ALL, demonstrating exquisite dependency of pre-BCR(+) B-ALL, but not other B-ALL subsets, on this signaling pathway. We demonstrate that SYK, PI3K/AKT, FOXO1 and MYC are important downstream mediators of pre-BCR signaling in B-ALL. Furthermore, we define a characteristic immune phenotype and gene expression signature of pre-BCR(+) ALL to distinguish them from other B-ALL subsets. These data provide comprehensive new insight into pre-BCR signaling in B-ALL and corroborate pre-BCR signaling and SYK as promising new therapeutic targets in pre-BCR(+) B-ALL.

SUBMITTER: Kohrer S 

PROVIDER: S-EPMC5459356 | biostudies-literature | 2016 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Pre-BCR signaling in precursor B-cell acute lymphoblastic leukemia regulates PI3K/AKT, FOXO1 and MYC, and can be targeted by SYK inhibition.

Köhrer S S   Havranek O O   Seyfried F F   Hurtz C C   Coffey G P GP   Kim E E   Ten Hacken E E   Jäger U U   Vanura K K   O'Brien S S   Thomas D A DA   Kantarjian H H   Ghosh D D   Wang Z Z   Zhang M M   Ma W W   Jumaa H H   Debatin K-M KM   Müschen M M   Meyer L H LH   Davis R E RE   Burger J A JA  

Leukemia 20160205 6


Precursor-B-cell receptor (pre-BCR) signaling and spleen tyrosine kinase (SYK) recently were introduced as therapeutic targets for patients with B-cell acute lymphoblastic leukemia (B-ALL), but the importance of this pathway in B-ALL subsets and mechanism of downstream signaling have not fully been elucidated. Here, we provide new detailed insight into the mechanism of pre-BCR signaling in B-ALL. We compared the effects of pharmacological and genetic disruption of pre-BCR signaling in vitro and  ...[more]

Similar Datasets

| S-EPMC5385842 | biostudies-literature
| S-EPMC6283070 | biostudies-literature
| S-EPMC4258248 | biostudies-literature
| S-EPMC5675611 | biostudies-literature
| S-EPMC2713461 | biostudies-literature
| S-EPMC3828226 | biostudies-literature
| S-EPMC8904819 | biostudies-literature
| S-EPMC3412346 | biostudies-literature
2009-12-01 | GSE14959 | GEO
| S-EPMC7478576 | biostudies-literature